Hypoglycemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Diagnosis== | ==Diagnosis== | ||
#Symptoms consistent with the diagnosis | |||
#Symptoms associated with a low glucose level, usually <50 | |||
#Symptoms resolve with glucose administration | |||
==DDX== | |||
# | #Medication-induced | ||
#Sepsis | |||
#Toxin | |||
#Insulinoma | |||
#Hepatic failure | |||
#Adrenal insufficiency | |||
# | |||
# | |||
# | |||
# | |||
# | |||
==Treatment == | ==Treatment == | ||
# | #Hypoglycemia from insulin | ||
# | ##D50 | ||
# | ##PO diet | ||
# | ##Glucagon | ||
# | ###Efficacy dependent on hepatic glycogen stores | ||
# | ###Onset of action slower than IV dextrose (7-10min) | ||
# | ###1mg SC or IM | ||
# | #Hypoglycemia from sulfonylureas | ||
# | ##D50 | ||
# | ##Octreotide | ||
# | ###Used to reduce risk of recurrent hypoglycemia | ||
#Octreotide | ###50-100mcg SC | ||
# | ##Do NOT use glucagon (stimulates insulin release) | ||
# | ##Consider admission for obs b/c of long duration of action and delayed clearance | ||
==See Also== | ==See Also== | ||
[[Diabetes (Meds)]] | *[[Diabetes (Meds)]] | ||
*[[Hypoglycemia (Peds)]] | |||
[[Hypoglycemia (Peds)]] | *[[Hypoglycemia (Neonatal)]] | ||
[[Hypoglycemia (Neonatal)]] | |||
==Source == | ==Source == | ||
Tintinalli | |||
[[Category:Endo]] | [[Category:Endo]] | ||
Revision as of 07:31, 27 September 2011
Diagnosis
- Symptoms consistent with the diagnosis
- Symptoms associated with a low glucose level, usually <50
- Symptoms resolve with glucose administration
DDX
- Medication-induced
- Sepsis
- Toxin
- Insulinoma
- Hepatic failure
- Adrenal insufficiency
Treatment
- Hypoglycemia from insulin
- D50
- PO diet
- Glucagon
- Efficacy dependent on hepatic glycogen stores
- Onset of action slower than IV dextrose (7-10min)
- 1mg SC or IM
- Hypoglycemia from sulfonylureas
- D50
- Octreotide
- Used to reduce risk of recurrent hypoglycemia
- 50-100mcg SC
- Do NOT use glucagon (stimulates insulin release)
- Consider admission for obs b/c of long duration of action and delayed clearance
See Also
Source
Tintinalli
